Background: Rectal carcinoma is a common malignancy, with a history of high
local recurrence rates following surgery. In recent years, preoperative ra
diotherapy and refined surgical technique have improved local control rates
.
Aim: To investigate the relationship between expression of nuclear p53 prot
ein and the outcome in rectal carcinoma, with and without short-term preope
rative radiotherapy.
Material: Specimens from 163 patients from the Southeast Swedish Health Car
e region included in the Swedish rectal cancer trial between 1987-1990.
Method, New sections from the paraffin blocks of the preoperative biopsy an
d the surgical specimen were examined immunohistochemically using a p53 ant
ibody (PAb 1801).
Result: Expression of nuclear p53 protein was seen in 41% of the rumours. T
he p53 negative patients treated with preoperative radiotherapy had a signi
ficant reduction of local failure compared with the non-irradiated p53 nega
tive patients (P = 0.0008). In contrast, p53 positive patients showed no be
nefit from preoperative radiotherapy. The interaction between p53 status an
d the benefit of radiotherapy was statistically significant (P = 0.018).
Conclusion: Expression of nuclear p53 protein in rectal carcinoma seems to
be a significant predictive factor for local treatment failure after preope
rative radiotherapy. Further investigations are necessary to select patient
s for preoperative treatment based on analysis of the preoperative biopsies
. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.